Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade) Feb 20, 2026
Vera Therapeutics announces $200M public offering Dec 8, 2025 Comments Vera Therapeutics (NASDAQ:ERA) stated on Monday that it had commenced a public offering to...
